Protocol No
GOG-3028/C-750-01
Principal Investigator
Denise Uyar
Phase
II
Description
To assess whether AGEN23034 administered alone or combination with another drug AGEN1884 response well to women with recurrent/persistent metastatic cervical cancer
Participating Institutions
Froedtert Hospital
Status
SRC APPROVAL
ClinicalTrials.gov